Perinatal selective serotonin reuptake inhibitor exposure and behavioral outcomes : A systematic review and meta-analyses of animal studies
Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved..
In the Western world, 2-5 % of pregnant women use selective serotonin reuptake inhibitor (SSRI) antidepressants. There is no consensus on the potential long-term neurodevelopmental outcomes of early SSRI exposure. Our aim was to determine whether there is an overall effect of perinatal SSRI exposure in animals on a spectrum of behavioral domains. After a comprehensive database search in PubMed, PsycINFO, and Web of Science, we included 99 publications. We performed nine meta-analyses and two qualitative syntheses corresponding to different behavioral categories, aggregating data from thousands of animals. We found evidence for reduced activity and exploration behavior (standardized mean difference (SMD) -0.28 [-0.38, -0.18]), more passive stress coping (SMD -0.37 [-0.52, -0.23]), and less efficient sensory processing (SMD -0.37 [-0.69, -0.06]) in SSRI- versus vehicle-exposed animals. No differences were found for anxiety (p = 0.06), social behavior, learning and memory, ingestive- and reward behavior, motoric behavior, or reflex and pain sensitivity. Exposure in the period equivalent to the human third trimester was associated with the strongest effects.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2020 |
---|---|
Erschienen: |
2020 |
Enthalten in: |
Zur Gesamtaufnahme - volume:114 |
---|---|
Enthalten in: |
Neuroscience and biobehavioral reviews - 114(2020) vom: 01. Juli, Seite 53-69 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Ramsteijn, A S [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 21.06.2021 Date Revised 07.12.2022 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.neubiorev.2020.04.010 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM309052157 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM309052157 | ||
003 | DE-627 | ||
005 | 20231225133051.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2020 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.neubiorev.2020.04.010 |2 doi | |
028 | 5 | 2 | |a pubmed24n1030.xml |
035 | |a (DE-627)NLM309052157 | ||
035 | |a (NLM)32320813 | ||
035 | |a (PII)S0149-7634(19)31120-0 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Ramsteijn, A S |e verfasserin |4 aut | |
245 | 1 | 0 | |a Perinatal selective serotonin reuptake inhibitor exposure and behavioral outcomes |b A systematic review and meta-analyses of animal studies |
264 | 1 | |c 2020 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 21.06.2021 | ||
500 | |a Date Revised 07.12.2022 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2020 The Authors. Published by Elsevier Ltd.. All rights reserved. | ||
520 | |a In the Western world, 2-5 % of pregnant women use selective serotonin reuptake inhibitor (SSRI) antidepressants. There is no consensus on the potential long-term neurodevelopmental outcomes of early SSRI exposure. Our aim was to determine whether there is an overall effect of perinatal SSRI exposure in animals on a spectrum of behavioral domains. After a comprehensive database search in PubMed, PsycINFO, and Web of Science, we included 99 publications. We performed nine meta-analyses and two qualitative syntheses corresponding to different behavioral categories, aggregating data from thousands of animals. We found evidence for reduced activity and exploration behavior (standardized mean difference (SMD) -0.28 [-0.38, -0.18]), more passive stress coping (SMD -0.37 [-0.52, -0.23]), and less efficient sensory processing (SMD -0.37 [-0.69, -0.06]) in SSRI- versus vehicle-exposed animals. No differences were found for anxiety (p = 0.06), social behavior, learning and memory, ingestive- and reward behavior, motoric behavior, or reflex and pain sensitivity. Exposure in the period equivalent to the human third trimester was associated with the strongest effects | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Meta-Analysis | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a Review | |
650 | 4 | |a Systematic Review | |
650 | 4 | |a Activity and exploration | |
650 | 4 | |a Animal studies | |
650 | 4 | |a Antidepressants | |
650 | 4 | |a Anxiety | |
650 | 4 | |a Behavior | |
650 | 4 | |a Developmental exposure | |
650 | 4 | |a Ingestive and reward behavior | |
650 | 4 | |a Learning and memory | |
650 | 4 | |a Meta-analysis | |
650 | 4 | |a Motoric behavior | |
650 | 4 | |a Offspring | |
650 | 4 | |a Pregnancy | |
650 | 4 | |a Reflex and pain sensitivity | |
650 | 4 | |a Selective serotonin reuptake inhibitors (SSRIs) | |
650 | 4 | |a Sensory processing | |
650 | 4 | |a Sleep and circadian activity | |
650 | 4 | |a Social behavior | |
650 | 4 | |a Stress coping | |
650 | 4 | |a Systematic review | |
650 | 4 | |a Teratogenic effects | |
650 | 7 | |a Antidepressive Agents |2 NLM | |
650 | 7 | |a Serotonin Uptake Inhibitors |2 NLM | |
700 | 1 | |a Van de Wijer, L |e verfasserin |4 aut | |
700 | 1 | |a Rando, J |e verfasserin |4 aut | |
700 | 1 | |a van Luijk, J |e verfasserin |4 aut | |
700 | 1 | |a Homberg, J R |e verfasserin |4 aut | |
700 | 1 | |a Olivier, J D A |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Neuroscience and biobehavioral reviews |d 1982 |g 114(2020) vom: 01. Juli, Seite 53-69 |w (DE-627)NLM000456977 |x 1873-7528 |7 nnns |
773 | 1 | 8 | |g volume:114 |g year:2020 |g day:01 |g month:07 |g pages:53-69 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.neubiorev.2020.04.010 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 114 |j 2020 |b 01 |c 07 |h 53-69 |